Results 31 to 40 of about 14,279 (236)

Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.

Journal of Lipid Research, 1995
For the last 30 years fibrates have been widely prescribed to treat human dyslipidemia. However, the primary mechanism by which they lower plasma lipid levels is still unknown.
S Haubenwallner, A.D. Essenburg, B.C. Barnett, M.E. Pape, R.B. DeMattos, B.R. Krause, L.L. Minton, B.J. Auerbach, R.S. Newton, T Leff   +9 more
doaj   +1 more source

PRODUCT OF PL FIBRATORS AS CODIMENSION-k FIBRATORS [PDF]

Communications of the Korean Mathematical Society, 2007
Summary: We describe some conditions under which the product of two groups with certain property is a group with the same property, and we describe some conditions under which the product of hopfian manifolds is another hopfian manifold. As applications, we find some PL fibrators among the product of fibrators.
Im, Young Ho, Kim, Yongkuk
openaire   +1 more source

Farmacologia do fibratos Pharmacology of fibrates

Arquivos Brasileiros de Cardiologia, 2005
Os fibratos são as drogas de escolha nas hipertrigliceridemias. Após sua absorção, os fibratos são metabolizados pelo fígado, utilizando isoenzimas P450 não compartilhadas pelas estatinas.
Hermes Toros Xavier
doaj   +1 more source

Análise da Revisão Cochrane: fibratos na prevenção secundária de doença cardiovascular e acidente vascular cerebral

Revista Portuguesa de Cardiologia, 2017
Resumo: A influência dos fibratos no risco cardiovascular tem sido o foco de vários ensaios clínicos. Esta revisão sistemática da Cochrane Collaboration avaliou o efeito dos fibratos na prevenção secundária de eventos cardiovasculares e acidente vascular
Gilberto Pires da Rosa, Diogo Libânio, Luís Filipe Azevedo   +2 more
doaj   +1 more source

Lipid metabolism dysregulation in diabetic retinopathy

Journal of Lipid Research, 2021
: Lipid metabolic abnormalities have emerged as potential risk factors for the development and progression of diabetic complications, including diabetic retinopathy (DR).
Julia V. Busik
doaj   +1 more source

Noncommutative fibrations [PDF]

Communications in Algebra, 2019
We show that faithfully flat smooth extensions are reduced flat, and therefore, fit into the Jacobi-Zariski exact sequence in Hochschild homology and cyclic (co)homology even when the algebras are noncommutative or infinite dimensional. We observe that such extensions correspond to étale maps of affine schemes, and we propose a definition for generic ...
openaire   +2 more sources

Searching for K3 fibrations [PDF]

Nuclear Physics B, 1997
21 pages, LaTeX2e, 4 eps figures, uses packages amssymb,latexsym,cite ...
Avram, A. C., Kreuzer, Maximilian, Mandelberg, I. Michael, Skarke, H.   +3 more
openaire   +3 more sources

Update on the Pharmacological Treatment of Primary Biliary Cholangitis

Biomedicines, 2022
Ursodeoxycholic acid (UDCA) is the first-line therapy used for the treatment of PBC. In recent years, new pharmacological agents have been proposed for PBC therapy to cure UDCA-non-responders.
Annarosa Floreani, Daniela Gabbia, Sara De Martin   +2 more
doaj   +1 more source

EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS PREVIOUSLY TREATED WITH FIBRATES OR OBETICHOLIC ACID

Annals of Hepatology
Introduction and Objectives: Seladelpar was evaluated as monotherapy or with ursodeoxycholic acid in RESPONSE (NCT04620733) among patients with primary biliary cholangitis.
Alejandra M. Villamil, Daniel Pratt, Andreas E. Kremer, Vincenza Calvaruso, Elena Gómez Dominguez, Xin Qi, Sarah Proehl, William T. Barchuk, Timothy R. Watkins, Stuart C. Gordon   +9 more
doaj   +1 more source

Mediterranean Diet and Physical Activity Decrease the Initiation of Cardiovascular Drug Use in High Cardiovascular Risk Individuals: A Cohort Study

Antioxidants, 2021
Our aim was to assess whether long-term adherence to a Mediterranean diet (MedDiet) and leisure-time physical activity (LTPA) were associated with a lower initiation of cardiovascular drug use.
Margarita Ribó-Coll, Sara Castro-Barquero, Camille Lassale, Emilio Sacanella, Emilio Ros, Estefanía Toledo, José V. Sorlí, Andrés Díaz-López, José Lapetra, Carlos Muñoz-Bravo, Fernando Arós, Miquel Fiol, Lluis Serra-Majem, Xavier Pinto, Olga Castañer, César I. Fernández-Lázaro, Olga Portolés, Nancy Babio, Ramón Estruch, Álvaro Hernáez   +19 more
doaj   +1 more source